Drug Shortage Report for MINT-SPIRONOLACTONE
Report ID | 169555 |
Drug Identification Number | 02488159 |
Brand name | MINT-SPIRONOLACTONE |
Common or Proper name | Spironolactone |
Company Name | MINT PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | SPIRONOLACTONE |
Strength(s) | 100MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 count bottle |
ATC code | C03DA |
ATC description | POTASSIUM-SPARING AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-09-19 |
Estimated end date | 2023-02-20 |
Actual end date | 2023-03-10 |
Shortage status | Resolved |
Updated date | 2023-03-13 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2023-03-13 | French | Compare |
v8 | 2023-03-13 | English | Compare |
v7 | 2023-01-30 | French | Compare |
v6 | 2023-01-30 | English | Compare |
v5 | 2023-01-03 | French | Compare |
v4 | 2023-01-03 | English | Compare |
v3 | 2022-09-20 | English | Compare |
v2 | 2022-09-19 | French | Compare |
v1 | 2022-09-19 | English | Compare |
Showing 1 to 9 of 9